FIELD: medicine, ophthalmology. SUBSTANCE: invention proposes a novel agent for treatment of traumatic conjunctivitis, blepharoconjunctivitis and keratitis. This agent is the polyvalent purified liquid pyobacteriophage. An agent shows not only the known antibacterial properties but anti-inflammatory and reparative properties also, it increases immunoglobulin concentration in tear and amount of active neutrophiles. Invention ensures to broaden the arsenal of drugs used for treatment of patients with traumatic bacterial conjunctivitis, blepharoconjunctivitis and keratitis. An agent does not cause allergic responses and irritation of eye mucosa. EFFECT: enhanced effectiveness of an agent, absence of adverse effects.
Title | Year | Author | Number |
---|---|---|---|
OCULAR OINTMENT | 1994 |
|
RU2082434C1 |
GEL DROPS FOR TREATING INFLAMMATORY EYE DISEASES, INCLUDING INFECTIOUS AND SUSTAINABLE TO ANTIBIOTICS DISEASES | 2017 |
|
RU2669768C1 |
PREPARATION FOR DIAGNOSIS OF DISEASES AND TRAUMAS OF EYE CORNEA | 1995 |
|
RU2142292C1 |
PREPARATION FOR DIAGNOSIS OF EYE CORNEA ILLNESS AND TRAUMA | 1995 |
|
RU2098089C1 |
PREPARATION FOR EYE CORNEA ILLNESS AND TRAUMA DIAGNOSIS | 1995 |
|
RU2097031C1 |
AGENT FOR TREATMENT OF PATIENT WITH HERPETIC KERATITIS | 1996 |
|
RU2135187C1 |
EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
METHOD FOR TREATING DEMODECOSIS BLEPHAROCONJUNCTIVITIS | 2003 |
|
RU2254838C1 |
METHOD FOR TREATING CHLAMYDEOUS CONJUNCTIVITIS | 2000 |
|
RU2187305C2 |
EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
Authors
Dates
1999-12-10—Published
1996-10-01—Filed